[The Impact of CD4+/CD8+ Ratio on the Efficacy of CAR-T Therapy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma] [0.03%]
CD4+/CD8+比率对复发/难治弥漫大B细胞淋巴瘤患者CAR-T治疗疗效的影响分析
Fan Xia,Qian Zhu,Jun-Hong Li et al.
Fan Xia et al.
Objective: To evaluate the predictive value of peripheral blood CD4+/CD8+ ratio immediately prior to chimeric antigen receptor T-cell (CAR-T) infusion (Day 0) for treatment efficacy in patients with relapsed/refractory di...
[Clinical Characteristics and Prognosis of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia] [0.03%]
淋巴浆细胞淋巴瘤/瓦尔登斯特伦巨球蛋白血症的临床特点和预后分析
Ying Pan,Cun-Ying Yao,Wen-Xuan Gao et al.
Ying Pan et al.
Objective: To explore the clinical features, treatment strategies, and prognostic factors of patients with new diagnosed Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM), thereby enhancing the diagnostic...
[Clinical Characteristics and Survival Analysis of Pediatric Non-Hodgkin Lymphoma in Fujian Province] [0.03%]
福建省儿童非霍奇金淋巴瘤临床特征及预后分析
Li-Li Pan,Yong-Zhi Zheng,Jian Li et al.
Li-Li Pan et al.
Objective: To summarize the clinicopathological characteristics and survival outcomes of pediatric non-Hodgkin lymphoma (NHL) in Fujian Province. Methods:...
[Analysis of the Gene Mutation Distribution and Its Relationship with Prognosis in Patients with Primary Gastrointestinal Diffuse Large B-Cell Lymphoma by Next Generation Sequencing] [0.03%]
基于下一代测序技术的原发胃肠道弥漫大B细胞淋巴瘤患者基因突变分布及预后的分析
Zhen Kou,Si-Ying Lin,Xiao-Long Qi et al.
Zhen Kou et al.
Objective: To investigate the gene mutations in tumor tissues of patients with primary gastrointestinal diffuse large B-cell lymphoma (PGI-DLBCL), and analyze its relationship with clinical features and prognosis. ...
[Infection Characteristics and Survival Status of Lymphoma Patients after Autologous Hematopoietic Stem Cell Transplantation with the Application of Intravenous Immunoglobulin] [0.03%]
预防用免疫球蛋白对自体造血干细胞移植后淋巴瘤患者感染特征及生存状态的影响
Bin Lyu,Xue-Jiao Gu,Ming-Xi Tian et al.
Bin Lyu et al.
Objective: To explore the infection characteristics and survival status of lymphoma patients who received intravenous immunoglobulin (IVIG) after autologous hematopoietic stem cell transplantation (AHSCT). ...
[The Effect of MiR-100-5p on the Biological Behaviors of Pediatric Acute Myeloid Leukemia Cells by Targeting IGF1R] [0.03%]
[通过靶向IGF1R微小RNA-100-5p对儿童急性髓系白血病细胞生物学行为的影响]
Ying Yang,Cong-Mei DU,Yin Sun et al.
Ying Yang et al.
Objective: To investigate the effect of miR-100-5p on the biological behaviors of pediatric acute myeloid leukemia (AML) cells by targeting insulin-like growth factor 1 receptor (IGF1R ). ...
[Analysis of Clinical Features of 32 Cases of Adult T-cell Leukemia/Lymphoma in a Single Center] [0.03%]
单中心32例成人T细胞白血病/淋巴瘤临床特点分析
Xiao-Bin Lin,Xiao-Hui Lai,Kuang-Fei Wang et al.
Xiao-Bin Lin et al.
Objective: To analyze the clinical characteristics and prognosis of adult T-cell leukemia/lymphoma (ATLL) patients. Methods: The clinic...
[Clinical Features and Prognosis of Patients with Hematologic Malignancies and Second Primary Cancer] [0.03%]
血液系统恶性肿瘤合并第二原发癌患者的临床特征及预后分析
Yue-Yue Pan,Hai-Lin Yang,Bo-Yu Xiong et al.
Yue-Yue Pan et al.
Objective: To explore the clinical characteristics and prognosis of second primary cancers (SPC) in patients with hematologic malignancies. Additionally, it aims to characterize hematologic malignancies that develop as SP...
[Daporinad Potently Induces Cell Death in Ph+ Acute Lymphoblastic Leukemia SUP-B15 Cells Independent of the Intrinsic Apoptotic Pathway] [0.03%]
[Daporinad诱导Ph+急性淋巴细胞白血病SUP-B15细胞凋亡独立于固有凋亡途径]
Jing-Jing Xi,Cong-Yue Wang,Jia-Min Zhan et al.
Jing-Jing Xi et al.
Objective: To investigate whether daporinad (APO866), a nicotinamide phosphoribosyltransferase (NAMPT) inhibitor, can potently kill Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) cells via an in...
[Establishment of a Doxorubicin-Resistant Acute Myeloid Leukemia Cell Line and Study on Its Drug Resistance Mechanisms] [0.03%]
多柔比星耐药急性髓系白血病细胞株的建立及其耐药机制的研究
Lu-Lu Feng,Yu-Ting Wang,Chao-Fan Huang et al.
Lu-Lu Feng et al.
Objective: To establish a doxorubicin (DOX)-resistant acute myeloid leukemia (AML) cell line and explore the mechanisms of its drug resistance. Methods: ...